Macleods Pharmaceuticals Ltd — Budesonide Exporter Profile
Indian Pharmaceutical Exporter · #10 for Budesonide · $511.6K export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #10 Indian exporter of Budesonide with $511.6K in export value and 29 verified shipments. Macleods Pharmaceuticals Ltd holds a 0.3% market share in Budesonide exports across 9 countries.
Macleods Pharmaceuticals Ltd — Budesonide Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Budesonide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| YEMEN | $172.8K | 4 | 31.6% |
| FRANCE | $124.9K | 13 | 22.8% |
| VENEZUELA | $70.3K | 3 | 12.8% |
| YEMEN, DEMOCRATIC | $69.4K | 2 | 12.7% |
| BARBADOS | $36.8K | 2 | 6.7% |
| VIETNAM | $23.3K | 2 | 4.3% |
| PAKISTAN | $17.2K | 2 | 3.1% |
| BOTSWANA | $10.2K | 2 | 1.9% |
| TANZANIA | $9.6K | 1 | 1.8% |
| YEMEN DEMOCRATIC | $6.8K | 3 | 1.2% |
Macleods Pharmaceuticals Ltd exports Budesonide to 12 countries. The largest destination is YEMEN accounting for 31.6% of Macleods Pharmaceuticals Ltd's Budesonide shipments, followed by FRANCE (22.8%) and VENEZUELA (12.8%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Budesonide from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| INMA PHARMA FOR IMPORT AND TRADE O | YEMEN | $138.8K | 3 |
| PLANETPHARMA | FRANCE | $124.9K | 13 |
| INMA PHARMA FOR IMPORT AND | YEMEN, DEMOCRATIC | $76.2K | 5 |
| BIUMAK PHARMACEUTICAL CA | VENEZUELA | $55.5K | 2 |
| ARMSTRONG HEALTHCARE INC | BARBADOS | $36.8K | 2 |
| INMA PHARMA FOR IMPORT AND HRIR P O BOX | YEMEN | $34.0K | 1 |
| CENTRAL PHARMACEUTICAL CPC1 JSC. | VIETNAM | $23.3K | 2 |
| ZUHOOR ELHAM LTD | PAKISTAN | $17.2K | 2 |
| BIUMAK PHARMACEUTICALS CA; | VENEZUELA | $14.8K | 1 |
| COSPHARM INVESTMENTS (BOTSWANA) | BOTSWANA | $10.2K | 2 |
Macleods Pharmaceuticals Ltd supplies Budesonide to 13 buyers globally. The largest buyer is INMA PHARMA FOR IMPORT AND TRADE O (YEMEN), followed by PLANETPHARMA (FRANCE) and INMA PHARMA FOR IMPORT AND (YEMEN, DEMOCRATIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Budesonide Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $70.6M worth of Budesonide through 9,145 shipments from 275 suppliers to 115 countries, serving 609 buyers globally. Macleods Pharmaceuticals Ltd contributes $511.6K to this total, accounting for 0.3% of India's Budesonide exports. Macleods Pharmaceuticals Ltd ships Budesonide to 12 countries through 13 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Budesonide Exports?
Macleods Pharmaceuticals Ltd's average Budesonide shipment value is $17.6K per consignment, based on 29 shipments totaling $511.6K. The largest destination is YEMEN (31.6% of Macleods Pharmaceuticals Ltd's Budesonide exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Budesonide Exporters?
Macleods Pharmaceuticals Ltd ranks #10 among 275 Indian Budesonide exporters with a 0.3% market share. The top 3 exporters are CIPLA LIMITED ($53.0M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($7.8M), ZYDUS LIFESCIENCES LIMITED ($2.4M). Macleods Pharmaceuticals Ltd processed 29 shipments to 9 destination countries.
What Budesonide Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| BUDESONIDE PRESSURISED INHALATION 200 MC | $50.0K | 1 |
| BUDETROL 200(FORMOTEROL FUMARATE AND BUDESONIDE POWDER FOR INHALATION 6MCG+ 200MCG)1X30 (42950 PAC) | $50.0K | 1 |
| BUNASE 200 MCG SPR DOSE F/200(BUDESONIDE | $46.3K | 2 |
| BUDETROL 100(FORMOTEROL FUMARATE AND BUDESONIDE POWDER FOR INHALATION 6MCG+ 100MCG)1X30 (38475 PAC) | $44.7K | 1 |
| BUDETROL 400(FORMOTEROL FUMARATE AND BUDESONIDE POWDER FOR INHALATION 6MCG+ 400 MCG)1X30 (24050 PAC) | $44.2K | 1 |
| BUDETROL 200 (FORMOTEROL/BUDESONIDE DPI | $41.6K | 1 |
| BUNASE 200(BUDESONIDE 200MCG INHALER MDI | $36.8K | 2 |
| BUDETROL 100 FORMOTEROL/BUDESONIDE DPICAPS 6/100MCG 1X30S 30000 PAC | $34.0K | 1 |
| BUDETROL 400 (FORMOTEROL/BUDESONIDE DPI | $27.9K | 1 |
| BUNASE 200 (BUDESONIDE INHALER 200MCG) - 1 X 1 | $23.3K | 1 |
Macleods Pharmaceuticals Ltd exports 28 distinct Budesonide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BUDESONIDE PRESSURISED INHALATION 200 MC with 1 shipments worth $50.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Budesonide Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | MEDISPRAY LABORATORIES PRIVATE LIMITED | $600.0K | 12 | 1 | $50.0K |
| 9 | ALTHEA PHARMA PRIVATE LIMITED | $578.6K | 119 | 1 | $4.9K |
| 10 | MACLEODS PHARMACEUTICALS LTD ★ | $511.6K | 29 | 9 | $17.6K |
| 11 | GLENMARK PHARMACEUTICALS LIMITED | $489.4K | 15 | 2 | $32.6K |
| 12 | NOBLE WELLNESS PRIVATE LIMITED | $372.9K | 10 | 2 | $37.3K |
Macleods Pharmaceuticals Ltd ranks #10 among 275 Indian Budesonide exporters. Average shipment value of $17.6K compared to the market average of $256.7K. The closest competitors by value are MEDISPRAY LABORATORIES PRIVATE LIMITED and ALTHEA PHARMA PRIVATE LIMITED.
Which Indian Ports Ship Budesonide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,990 | 21.8% |
| DELHI AIR CARGO ACC (INDEL4) | 1,616 | 17.7% |
| DELHI AIR | 1,404 | 15.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,213 | 13.3% |
| Delhi Air | 419 | 4.6% |
| Bombay Air | 386 | 4.2% |
| NHAVA SHEVA SEA (INNSA1) | 303 | 3.3% |
| Delhi Air Cargo | 152 | 1.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Budesonide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Budesonide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 36 individual customs records matching Macleods Pharmaceuticals Ltd exporting Budesonide, covering 28 formulations to 12 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 609+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Budesonide Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Budesonide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Budesonide Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Budesonide. For current shipment-level data, contact TransData Nexus.